The Ohio State University Comprehensive Cancer Center
‘Be very suspicious’: Staging of early pancreatic cancer inaccurate up to 80% of the time
Nearly 80% of individuals clinically diagnosed with stage I pancreatic ductal adenocarcinoma and close to 30% diagnosed with stage II disease got upstaged after surgery, according to retrospective study results.
Ohio State names new medical oncology director
Christian Rolfo, MD, PhD, MBA, will be the director of the division of medical oncology at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, as of Aug. 15.
‘We were shocked’: Vaping considerably increases lung cancer risk among people who smoke
People who vaped and smoked cigarettes appeared four times more likely to develop lung cancer compared with those who only smoked, according to study results presented at American Association for Cancer Research Annual Meeting.
Metformin may reduce risk for overall cancer, GI malignancies, meta-analysis shows
The commonly used diabetes drug metformin may reduce risk for cancer, according to study results published in Journal of the National Cancer Institute.
Cancer information on social media: Potential value, but take ‘with a grain of salt’
An analysis of gynecologic cancer content on TikTok provided new insights into the advantages and disadvantages of patients using social media.
Ohio State appoints surgical oncology division chief
Susan Tsai, MD, has been appointed chief of the division of surgical oncology at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
National Comprehensive Cancer Network awards grants for small cell lung cancer research
National Comprehensive Cancer Network’s Oncology Research Program awarded three grants to support research into small cell lung cancer.
High allostatic load linked to all-cause mortality among patients with breast cancer
High allostatic load appeared associated with increased risk for all-cause mortality among patients with breast cancer, according to study results published in JAMA Network Open.
Venetoclax regimen not superior to standard therapy alone for older patients with CLL
CHICAGO — The addition of venetoclax to ibrutinib and obinutuzumab did not extend PFS among older patients with treatment-naive chronic lymphocytic leukemia during the COVID-19 pandemic, according to data presented at ASCO Annual Meeting.
Elevated BMI in adulthood may increase GI cancer risk, regardless of aspirin use
Overweight and obese BMI during adulthood appeared associated with increased risk for colorectal cancer and noncolorectal gastrointestinal cancers, according to study results published in JAMA Network Open.